https://www.selleckchem.com/pr....oducts/proteinase-k.
At 2 years, the median difference (95% credibility interval) between IVT-AFL TE and RBZ TE regarding the numbers of Early Treatment Diabetic Retinopathy Study (ETDRS) letters gained was not significant (M1 - 2.29 [- 8.10, 3.58]; M2 - 0.55 [- 6.34, 5.29]). IVT-AFL TE was associated with significantly fewer injections than RBZ-TE (M1 - 6.12 [- 7.60, - 4.65]; M2 - 5.93 [- 7.42, - 4.45]). Results of the sensitivity analyses were consistent with the main scenarios. CONCLUSION Patients with wAMD receiving an IVT-AFL T
Like
Comment
Share
